Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression
Authors
Keywords
B7H3, CD14<sup>+</sup> monocytes, Renal cell carcinoma, Angiogenesis
Journal
MEDICAL ONCOLOGY
Volume 31, Issue 12, Pages -
Publisher
Springer Nature
Online
2014-11-22
DOI
10.1007/s12032-014-0349-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
- (2014) J Kraan et al. BRITISH JOURNAL OF CANCER
- Human adipose tissue-resident monocytes exhibit an endothelial-like phenotype and display angiogenic properties
- (2014) Amparo Navarro et al. Stem Cell Research & Therapy
- The role of immune-related myeloid cells in angiogenesis
- (2013) Sarah E.J. Chambers et al. IMMUNOBIOLOGY
- B7-H3-mediated tumor immunology: Friend or foe?
- (2013) Ling Wang et al. INTERNATIONAL JOURNAL OF CANCER
- The role of monocyte subsets in myocutaneous revascularization
- (2013) Bilal Khan et al. JOURNAL OF SURGICAL RESEARCH
- The Role of Monocytes in Angiogenesis and Atherosclerosis
- (2013) Anthony S. Jaipersad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identification and Characterization of Angiogenesis Targets through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues
- (2013) Mehdi Mesri et al. PLoS One
- B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
- (2013) Xiao Qin et al. OncoTargets and Therapy
- Pro-angiogenic CD14++ CD16+ CD163+ monocytes accelerate the in vitro endothelialization of soft hydrophobic poly(n-butyl acrylate) networks
- (2012) Anke Mayer et al. Acta Biomaterialia
- The diverse identity of angiogenic monocytes
- (2012) Julie Favre et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer
- (2012) Janelle M. Fauci et al. GYNECOLOGIC ONCOLOGY
- Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
- (2012) Yishan Liu et al. INTERNATIONAL JOURNAL OF UROLOGY
- SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset
- (2011) A. M. Zawada et al. BLOOD
- Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
- (2011) Andreas Brunner et al. GYNECOLOGIC ONCOLOGY
- Combined implantation of CD34+and CD14+cells increases neovascularization through amplified paracrine signalling
- (2011) G. Krenning et al. Journal of Tissue Engineering and Regenerative Medicine
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
- (2011) Hexing Yuan et al. JOURNAL OF UROLOGY
- Brain-Specific Angiogenesis Inhibitor 1 is a Putative Factor for Inhibition of Neovascular Formation in Renal Cell Carcinoma
- (2011) Toshikazu Izutsu et al. JOURNAL OF UROLOGY
- Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors
- (2010) Shree Gopal Sharma et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell Carcinoma
- (2009) Henk M.W. Verheul et al. UROLOGY
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma
- (2008) P. L. Crispen et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now